The European biotech ecosystem: EBE position paper recommends how to make funding go further
The European Biopharmaceutical Enterprises (EBE) today published a White Paper that scrutinises funding available for innovative biopharmaceutical entrepreneurs in Europe and explores why fewer successful businesses are built in Europe – despite our exceptional science – than in other world regions. While welcoming the funding opportunities available in Europe, EBE has identified a number